| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/14/2002 | US6387406 Copolymer compositions for oral delivery |
| 05/14/2002 | US6387404 Immediate release tablet cores of insoluble drugs having sustained-release coating |
| 05/14/2002 | US6387403 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 05/14/2002 | US6387402 Pulverulent sorbitol and its process of preparation |
| 05/14/2002 | US6387401 Use of lipids as adjuvents in the production of solid medicinal forms by the melt extrusion process |
| 05/14/2002 | US6387400 Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 05/14/2002 | US6387399 Microencapsulated bioactive agents and method of making |
| 05/14/2002 | US6387398 Process for producing cosmetic and pharmaceutical formulations, and products comprising same |
| 05/14/2002 | US6387397 Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery |
| 05/14/2002 | US6387396 In gene therapy and in in vitro and in vivo transfection |
| 05/14/2002 | US6387395 N-[1, (1-1) -dialkyloxy] - and N- [1, (1-1) -dialkenyloxy]- alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| 05/14/2002 | US6387394 Controlled release insufflation carrier for medicaments |
| 05/14/2002 | US6387393 Medicated animal foodstuffs |
| 05/14/2002 | US6387392 Comprising a pressure-sensitive adhesive layer containing a drug on a cloth which prevents the dilution of drug by saliva |
| 05/14/2002 | US6387391 Bioresorbable polymeric clayey and sticky substance |
| 05/14/2002 | US6387390 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 05/14/2002 | US6387383 Topical low-viscosity gel composition |
| 05/14/2002 | US6387382 Water-proof, respirable, skin barrier composition |
| 05/14/2002 | US6387381 Carrier mixture of starch, oil, alcohol, sugar, water and salt |
| 05/14/2002 | US6387373 Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants |
| 05/14/2002 | US6387363 Absorbable sutures; synthetic lactic acid and glycolic acid copolylactone; each successive monomer can be specifically specified; cell-free translation system; synthetic messenger ribonucleic acid (mrna) as a template |
| 05/14/2002 | US6387351 Hair-care composition comprising an aqueous polymer dispersion |
| 05/14/2002 | US6386869 Oral therapeutic delivery appliance |
| 05/14/2002 | CA2361160A1 Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt |
| 05/14/2002 | CA2263905C Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| 05/14/2002 | CA2234235C Gel formulations containing growth factors |
| 05/14/2002 | CA2205046C Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and speed of dissolution |
| 05/14/2002 | CA2179540C Accelerated release composition containing bromocriptine |
| 05/14/2002 | CA2152696C Process for preparing natural active ingredient-containing spheroids, such as from plants; spheroids thus produced |
| 05/14/2002 | CA2129287C Use of cloprostenol, fluprostenol and their analogues to treat glaucoma and ocular hypertension |
| 05/14/2002 | CA2121038C Oral preparation for release in lower digestive tracts |
| 05/14/2002 | CA2089657C Topical treatment of blepharitis |
| 05/14/2002 | CA2079509C Prolonged release microparticle preparation and production of the same |
| 05/14/2002 | CA2040141C Biodegradable high-molecular polymers, production and use therof |
| 05/14/2002 | CA2034849C Equine aerosol drug delivery method and apparatus |
| 05/14/2002 | CA2033418C Pharmaceutical preparation for oral administration in fluid form |
| 05/14/2002 | CA2028234C Cellulosic coating |
| 05/10/2002 | WO2002036792A2 Dna expression vectors |
| 05/10/2002 | WO2002036767A2 Therapeutic oligonucleotides of reduced toxicity |
| 05/10/2002 | WO2002036737A2 Plant extract that inhibits release of tnf-alpha |
| 05/10/2002 | WO2002036634A2 Gene regulation therapy involving ferritin |
| 05/10/2002 | WO2002036600A2 Derivatised carbohydrates and their use in solid delivery systems |
| 05/10/2002 | WO2002036592A1 Remedies for arachidonic acid-induced skin diseases |
| 05/10/2002 | WO2002036582A1 Stable pharmaceutical form of an anticancer drug |
| 05/10/2002 | WO2002036571A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
| 05/10/2002 | WO2002036543A1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride |
| 05/10/2002 | WO2002036257A1 Method and device for producing lipid vesicles |
| 05/10/2002 | WO2002036184A1 Implantable medical device for delivering a liquid |
| 05/10/2002 | WO2002036175A2 Sustained release device for treating conditions of the joint |
| 05/10/2002 | WO2002036169A2 Methods and compositions for enhanced delivery of bioactive molecules |
| 05/10/2002 | WO2002036167A1 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 05/10/2002 | WO2002036163A2 Novel medicament compositions consisting of tiotropium salts and antihistamines for treating respiratory illnesses |
| 05/10/2002 | WO2002036158A1 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses |
| 05/10/2002 | WO2002036156A1 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 05/10/2002 | WO2002036145A2 Kahalalide f formulation |
| 05/10/2002 | WO2002036144A1 Gnrh analogues for treatment of urinary incontinence |
| 05/10/2002 | WO2002036143A1 Inhibition or reversal of skin aging by actin-sequestering peptides |
| 05/10/2002 | WO2002036140A2 Use of a preparation of cimicifuga racemosa |
| 05/10/2002 | WO2002036130A1 Veterinary composition for the topical treatment of traumatized or inflamed skin |
| 05/10/2002 | WO2002036127A2 Methods and compositions for the treatment of polycystic ovary syndrome with chromium complexes |
| 05/10/2002 | WO2002036126A1 Rapidly disintegrating sustained release cefuroxime axetil composition |
| 05/10/2002 | WO2002036110A2 Oral self-emulsifying formulations of pyranone protease inhibitors |
| 05/10/2002 | WO2002036106A2 Novel medicament compositions based on anticholinergics and corticosteroids |
| 05/10/2002 | WO2002036104A2 Inhalative solution formulation containing a tiotropium salt |
| 05/10/2002 | WO2002036103A1 Transdermal drug delivery system with improved water absorbability and adhesion properties |
| 05/10/2002 | WO2002036101A1 Novel dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications |
| 05/10/2002 | WO2002036100A1 Controlled release metformin compositions |
| 05/10/2002 | WO2002036099A1 Controlled release hydrocodone formulations |
| 05/10/2002 | WO2002036098A1 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine |
| 05/10/2002 | WO2002036097A2 Delivery system for entrapping charged macromolecules and a method for preparing same |
| 05/10/2002 | WO2002036096A2 Non-aspirating transitional viscoelastics for use in surgery |
| 05/10/2002 | WO2002036092A2 Mixture for treating skin |
| 05/10/2002 | WO2002036085A1 Expanded perborate salt, use, and method of production |
| 05/10/2002 | WO2002036077A2 Once a day antihistamine and decongestant formulation |
| 05/10/2002 | WO2002036073A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same |
| 05/10/2002 | WO2002036072A2 Method for short-term and long-term drug dosimetry |
| 05/10/2002 | WO2002036055A1 Biodegradable microbicidal vaginal barrier device |
| 05/10/2002 | WO2002035991A2 Spherical particles produced by a hot-melt extrusion/spheronization process |
| 05/10/2002 | WO2002035941A1 Precipitation of proteins from organic solutions |
| 05/10/2002 | WO2002035931A1 Hydrophilic polymer blends used for dry cow therapy |
| 05/10/2002 | WO2002020057A3 Flavoring systems for pharmaceutical compositions and methods of making such compositions |
| 05/10/2002 | WO2002009668A3 Pulmonary administration of flint |
| 05/10/2002 | WO2002007674A9 Enhancing compound penetration into hair follicles |
| 05/10/2002 | WO2002007520A3 Antimicrobial composition useful for the treatment of bovine mastitis |
| 05/10/2002 | WO2002005789A3 Solution-, dispersion- or emulsion-producing film dermatics |
| 05/10/2002 | WO2002003966A3 Method and materials for controlling migration of binder liquid in a powder |
| 05/10/2002 | WO2002003954A3 Non swellable suppository comprising at least one biocompatible, non-biodegradable polymer and a controlled release formulation |
| 05/10/2002 | WO2002000246A3 Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency |
| 05/10/2002 | WO2001097813A3 Highly concentrated stable meloxicam solutions |
| 05/10/2002 | WO2001093890B1 Botulinum toxin implant |
| 05/10/2002 | WO2001093827B1 Neurotoxin implant |
| 05/10/2002 | WO2001091727A3 Self-emulsifying active substance formulation and use of this formulation |
| 05/10/2002 | WO2001091722A3 Water-thin emulsions with low emulsifier levels |
| 05/10/2002 | WO2001091718A3 Occlusive transdermal therapeutic system wit a non-occlusive backing layer |
| 05/10/2002 | WO2001085143A3 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents |
| 05/10/2002 | WO2001074329A3 Sustained release beadlets containing stavudine |
| 05/10/2002 | WO2001068135A3 Compositions and methods for affecting osteogenesis |
| 05/10/2002 | WO2001064214A3 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| 05/10/2002 | WO2001057234A3 Biopolymer thickener |
| 05/10/2002 | WO2001051087A3 Novel treatment for eye disease |